Filing Details

Accession Number:
0001232524-18-000146
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-13 18:38:04
Reporting Period:
2018-08-09
Accepted Time:
2018-08-13 18:38:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1576068 Ann Heather Mcsharry 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-08-09 1,495 $0.00 8,219 No 4 A Direct
Ordinary Shares Disposition 2018-08-10 715 $176.61 7,504 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Non-Qualified Stock Option (right to buy) Acquisiton 2018-08-09 3,735 $0.00 3,735 $177.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,735 2028-08-08 No 4 A Direct
Footnotes
  1. These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 2, 2019.
  2. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  3. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $176.61 to $176.9217. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  4. These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2018.